Occurrence of serious infection among patients with rheumatoid arthritis or psoriatic arthritis concurrently exposed to an immunosuppressive biologic and denosumab: US physician practice chart review study (20150207)

01/12/2015
31/03/2024
EU PAS number:
EUPAS11662
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Amgen Prolia Protocol ORRG postreview V7.0

English (286.31 KB - PDF) View document
Updated protocol

Amgen Prolia Protocol V2.0 (amendment) clean (10)

First published: 22/02/2024
English (609.32 KB - PDF) View document
Study results
Study results

Abstract from 01.09.01 Clinical Study Report 2017-08-29 20150207 Final r...

English (125.68 KB - PDF) View document
Study report
Other information